ERK2 antibody (C-Term)
Quick Overview for ERK2 antibody (C-Term) (ABIN3003077)
Target
See all ERK2 (MAPK1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 316-345, C-Term
-
Purification
- This antibody is purified through a protein A column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide between 316-345 amino acids from the C-terminal region of human MAPK1.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 2-8 °C for up to two weeks. Aliquot and store at -20 °C for long term storage. Avoid repeated freeze/thaw cycles.
-
-
- ERK2 (MAPK1) (Mitogen-Activated Protein Kinase 1 (MAPK1))
-
Alternative Name
- MAPK1
-
UniProt
- P28482
-
Pathways
- MAPK Signaling, RTK Signaling, Apoptosis, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Monocarboxylic Acid Catabolic Process, Autophagy, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, BCR Signaling, S100 Proteins
Target
-